Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rosa de Miguel, Rocio Montejano, Natalia Stella-Ascariz & Jose R. Arribas. (2018) A safety evaluation of raltegravir for the treatment of HIV. Expert Opinion on Drug Safety 17:2, pages 217-223.
Read now
Read now
Tae Eun Park, Abdilahi Mohamed, Julie Kalabalik & Roopali Sharma. (2015) Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection. Expert Review of Anti-infective Therapy 13:10, pages 1195-1212.
Read now
Read now
Articles from other publishers (12)
Mehak Singh, Manoj Pawar, Shashank Bhargava, Prakhar Gupta & Pankaj Adhicari. (2021)
A novel association of efavirenz induced severe cutaneous adverse reactions with
HLA
‐
DRB1
*03:01: A case‐control study from
North‐East
India
. Dermatologic Therapy.
Crossref
Crossref
Maeva Lefebvre, Alexandre Walencik, Clotilde Allavena, Eric Billaud, Alain Kassi, Anne Cesbron, Caroline Joyau, Solène Secher, Anne-Lise Ruellan & François Raffi. (2020) Rate of DRESS Syndrome With Raltegravir and Role of the HLA-B*53:01 Allele. JAIDS Journal of Acquired Immune Deficiency Syndromes 85:4, pages e77-e80.
Crossref
Crossref
Walter de A. Eyer-Silva, Guilherme A. Rosa da Silva & Jorge F. da Cunha Pinto. (2019) Acute myocarditis after switch to dolutegravir. AIDS 33:13, pages 2105-2107.
Crossref
Crossref
Mark Thomas, Chris Hopkins, Eamon Duffy, Daniel Lee, Pierre Loulergue, Diego Ripamonti, David A. Ostrov & Elizabeth Phillips. (2017) Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. Clinical Infectious Diseases 64:9, pages 1198-1203.
Crossref
Crossref
Felicia A. Scaggs, Mariam S. Aziz, Erica L. Palmisano, Mahboobeh Mahdavinia, Sheela S. Raikar & Latania K. Logan. (2016) Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child. Annals of Allergy, Asthma & Immunology 117:6, pages 719-721.
Crossref
Crossref
Christopher B. Bunker & Vincent Piguet. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
58
.
Brigitte Milpied-Homsi, Ellen M. Moran & Elizabeth J. Phillips. (2014) Antiviral Drug Allergy. Immunology and Allergy Clinics of North America 34:3, pages 645-662.
Crossref
Crossref
Diego Ripamonti, Simone Vasiliji Benatti, Elisa Di Filippo, Veronica Ravasio & Marco Rizzi. (2014) Drug reaction with eosinophilia and systemic symptoms associated with raltegravir use. AIDS 28:7, pages 1077-1079.
Crossref
Crossref
Agnès Samain, Anne-Bénédicte Duval-Modeste, Pascal Joly, Céline Leblanc, Nathalie Massy, Philippe Courville, Odile Goria & Ghassan Riachi. (2014) First case of drug rash eosinophilia and systemic symptoms due to boceprevir. Journal of Hepatology 60:4, pages 891-893.
Crossref
Crossref
Isobel D. Ramsay, Jodi M. Lestner, Catherine P. O’Sullivan, Ana L.G. Cruz, Ho Kwong Li & Charlotte I.S. Barker. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
401
443
.
Melissa E O Perry, Noor Almaani, Nemesha Desai, Nick Larbalestier, Julie Fox & Daniella Chilton. (2013) Raltegravir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome – Implications for clinical practice and patient safety. International Journal of STD & AIDS 24:8, pages 639-642.
Crossref
Crossref
S. Ständer, D. Metze, T. Luger & T. Schwarz. (2013) Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Der Hautarzt 64:8, pages 611-624.
Crossref
Crossref